Ghasempour, S.* ; Warner, N.* ; Guan, R.* ; Rodari, M.M.* ; Ivanochko, D.* ; Whittaker Hawkins, R.* ; Marwaha, A.* ; Nowak, J.K.* ; Liang, Y.* ; Mulder, D.J.* ; Stallard, L.* ; Li, M.* ; Yu, D.D.* ; Pluthero, F.G.* ; Batura, V.* ; Zhao, M.* ; Siddiqui, I.* ; Upton, J.E.M.* ; Hulst, J.M.* ; Kahr, W.H.A.* ; Mendoza-Londono, R.* ; Charbit-Henrion, F.* ; Hoefsloot, L.H.* ; Khiat, A.* ; Moreira, D.* ; Trindade, E.* ; Espinheira, M.D.C.* ; Pinto Pais, I.* ; Weerts, M.J.A.* ; Douben, H.* ; Kotlarz, D.M. ; Snapper, S.B.* ; Klein, C.* ; Dowling, J.J.* ; Julien, J.P.* ; Joosten, M.* ; Cerf-Bensussan, N.* ; Freeman, S.A.* ; Parlato, M.* ; van Ham, T.J.* ; Muise, A.M.*
Human ITGAV variants are associated with immune dysregulation, brain abnormalities, and colitis.
J. Exp. Med. 221:e20240546 (2024)
Integrin heterodimers containing an Integrin alpha V subunit are essential for development and play critical roles in cell adhesion and signaling. We identified biallelic variants in the gene coding for Integrin alpha V (ITGAV) in three independent families (two patients and four fetuses) that either caused abnormal mRNA and the loss of functional protein or caused mistargeting of the integrin. This led to eye and brain abnormalities, inflammatory bowel disease, immune dysregulation, and other developmental issues. Mechanistically, the reduction of functional Integrin αV resulted in the dysregulation of several pathways including TGF-β-dependent signaling and αVβ3-regulated immune signaling. These effects were confirmed using immunostaining, RNA sequencing, and functional studies in patient-derived cells. The genetic deletion of itgav in zebrafish recapitulated patient phenotypes including retinal and brain defects and the loss of microglia in early development as well as colitis in juvenile zebrafish with reduced SMAD3 expression and transcriptional regulation. Taken together, the ITGAV variants identified in this report caused a previously unknown human disease characterized by brain and developmental defects in the case of complete loss-of-function and atopy, neurodevelopmental defects, and colitis in cases of incomplete loss-of-function.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Keywords plus
Language
english
Publication Year
2024
Prepublished in Year
0
HGF-reported in Year
2024
ISSN (print) / ISBN
0022-1007
e-ISSN
1540-9538
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 221,
Issue: 12,
Pages: ,
Article Number: e20240546
Supplement: ,
Series
Publisher
Rockefeller University Press
Publishing Place
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
Institute(s)
Institute of Translational Genomics (ITG)
POF-Topic(s)
30205 - Bioengineering and Digital Health
Research field(s)
Genetics and Epidemiology
PSP Element(s)
G-506700-001
Grants
Lassonde Family Precision IBD Initiative
Canadian Institute for Advanced Research
Canada Research Chair Program
Canada Foundation for Innovation
Ontario Research Foundation
Institut National de la Santé et de la Recherche Médicale
Fondation Princesse Grace de Monaco
Leona M. and Harry B. Helmsley Charitable Trust
CIHR Foundation Grant
Government of Ontario
Hospital for Sick Children
Copyright
Erfassungsdatum
2024-11-20